Skip to main content
Fig. 4 | BMC Urology

Fig. 4

From: NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo

Fig. 4

The effects of enforced NEAT1 on tumour growth and metastasis of BC. A The tumour implant was established as an orthotopic bladder cancer model, leading to tumorigenicity in vivo (the bladder model is marked by the red arrow). B The bladder weight of mice was significantly increased in the NEAT1 group; **p < 0.05 NEAT1 group versus CON and NC groups. C–H Histopathological cell morphology of the bladder, liver, lung, kidney, stomach and heart tissues was examined by H&E staining (magnification, × 200). Bladder cancer cells showed high-grade dysplasia, disorder, hyperchromatic nuclei and nuclear division in bladder tissues in all groups (the cancer cell is marked by the black arrow). Liver metastasis occurred only in the NEAT1 group, as indicated by necrosis of large numbers of hepatocytes and infiltration of cancer cells (the metastatic foci is marked by the black arrow). No metastatic lesions were detected in the lung, kidney, stomach and heart, in the three groups

Back to article page